Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome

類似資料

• Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome
  著者:: Philips, Ashwin, 等
  出版事項: (2018)
• Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
  著者:: Cammalleri, Lisa, 等
  出版事項: (2007)
• A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome
  著者:: Vadhan-Raj, S., 等
  出版事項: (2012)
• One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignancies
  著者:: Azim, Hamdy A, 等
  出版事項: (2013)
• Single dose rasburicase in the management of tumor lysis syndrome in childhood acute lymphoblastic leukemia: A case series
  著者:: Latha, S. M., 等
  出版事項: (2015)